Botulinum toxin pharmaceutical compositions

Details for Australian Patent Application No. 2001233315 (hide)

Owner Allergan Sales, Inc.

Inventors Hunt, Terrence J

Agent Davies Collison Cave

Pub. Number AU-B-2001233315

PCT Pub. Number WO01/58472

Priority 09/500,147 08.02.00 US

Filing date 5 February 2001

Wipo publication date 20 August 2001

Acceptance publication date 8 July 2004

International Classifications

A61K 038/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 047/22 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Heterocyclic compounds

A61K 047/42 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61K 047/36 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 047/16 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing nitrogen

Event Publications

8 July 2004 Application Accepted

  Published as AU-B-2001233315

4 November 2004 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001233316-Stent introducer apparatus

2001233314